299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,696 / Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02782312 (ClinicalTrials.gov)	June 2011	17/5/2016	Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis	Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis With Airway Limitation: a Prospective Study	Bronchiectasis	Drug: ICS+LABA;Other: routine therapy	Shanghai Pulmonary Hospital, Shanghai, China	NULL	Completed	18 Years	N/A	Both	120	Phase 4	China
2	NCT00220259 (ClinicalTrials.gov)	May 2001	20/9/2005	Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)	Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)	Cystic Fibrosis	Drug: Fluticasone or placebo	Royal Brompton & Harefield NHS Foundation Trust	Cystic Fibrosis Trust;GlaxoSmithKline	Completed	6 Years	N/A	Both	240	N/A	United Kingdom